Blindness News and Research

RSS

Samoa shuts down country for mass measles vaccinations

The Pacific island nation of Samoa will shut down its government services for two days while officials try to stem a deadly measles outbreak that killed 53, 48 of whom were children between 0 and 4 years old and sickened 3,728 people.

3 Dec 2019

Zebrafish study supports accuracy of CRISPR-Cas9 gene editing tool

Along with the promise that CRISPR-Cas9 gene editing technology can offer new human therapies is the need to ensure its safety. A recent study showed that CRISPR-Cas9 did not produce off-target gene mutations in zebrafish. These results, published in Frontiers in Genetics, confirm previous data in animal models that the risk to the rest of the genome from gene editing is minimal.

3 Dec 2019

Helper protein exacerbates diabetic macular edema

In a recent study using mice, lab-grown human retinal cells and patient samples, Johns Hopkins Medicine scientists say they found evidence of a new pathway that may contribute to degeneration of the light sensitive tissue at the back of the eye.

27 Nov 2019

Stem cells do not take the day off on national holidays

While most of us are stuffing ourselves with turkey and pumpkin pie at home on Thanksgiving Day, the staff at one Cedars-Sinai laboratory will be on the job, feeding stem cells.

26 Nov 2019

Glaucoma risk increased by air pollution

The more polluted the air, the higher the risk is that those who live in that area will develop glaucoma, says an interesting new study from the UK, published today in the journal Investigative Ophthalmology and Visual Science.

25 Nov 2019

Air pollution associated with greater risk of glaucoma

Living in a more polluted area is associated with a greater likelihood of having glaucoma, a debilitating eye condition that can cause blindness, finds a new UCL-led study in the UK.

25 Nov 2019

'African eye worm' hampers efforts to eliminate river blindness, study shows

Efforts to eliminate river blindness, a debilitating disease affecting millions in Africa, will be hampered by another parasitic infection known as Loiasis, or 'African eye worm,' according to a study published in Clinical Infectious Diseases.

20 Nov 2019

CTF, DELopen jointly offer unique opportunities to neurofibromatosis research community

The Children's Tumor Foundation, an innovative and global neurofibromatosis (NF) research foundation announced today a collaboration with DELopen, a DNA-encoded library technology platform sponsored by WuXi AppTec, a leading global provider of R&D and manufacturing services enabling companies in the pharmaceutical, biotechnology and medical device industries.

19 Nov 2019

Study of 'face blindness' provides clues to what goes wrong in the brain

People with prosopagnosia, or "face blindness," have trouble recognizing faces -- even those of close friends and family members.

19 Nov 2019

WHO announces two-year scheme to drive down the price of insulin

The World Health Organization plans to make insulin more affordable for the millions of people suffering from diabetes.

18 Nov 2019

Ramping up the body's waste disposal system helps heal diabetics' blood vessels

Research published today in Experimental Physiology shows that ramping up one of the body's waste disposal system, called autophagy, helps heal the blood vessels of diabetics.

17 Nov 2019

Nutraceuticals could help prevent diabetes

Diabetes mellitus is among the fastest-growing conditions in the world, and in Australia, a new case is diagnosed every 5 minutes. Many people with this illness are now taking diet supplements in an attempt to prevent this condition.

17 Nov 2019

Study shows importance of targeted antibody treatment for patients with wet macular degeneration

Wet age-related macular degeneration is one of the leading causes of blindness in the U.S. Breakthrough treatments come with a steep price tag and treatment burden for the patient, but a new study suggests their benefits to patient health and society top billions of dollars, or more, if adherence could be improved.

15 Nov 2019

Survey highlights the need to better educate people on risk factors of type 2 diabetes

Merck, a leading science and technology company, today released the results of research that has shown a lack of knowledge about the risk factors associated with type 2 diabetes internationally.

15 Nov 2019

Improved method for predicting retinopathy of prematurity could reduce unnecessary tests

A multicenter group of 41 hospitals led by researchers at Children's Hospital of Philadelphia (CHOP) has confirmed that an improved method for predicting retinopathy of prematurity (ROP), a leading cause of blindness in children, was able to reduce the number of babies having invasive diagnostic examinations by nearly a third, while raising disease detection up to 100 percent.

14 Nov 2019

Understanding how pressure is regulated in the eye could lead to new treatments for glaucoma

Scientists in the University of Arizona Department of Physiology have identified a potential molecular mechanism that may hold the key to understanding how pressure is regulated in the eye.

14 Nov 2019

FDA grants acceptance to application for selumetinib as treatment for neurofibromatosis

AstraZeneca and MSD (Merck) announced today that the U.S. Food and Drug Administration (FDA) has granted acceptance to file status of its application for the MEK inhibitor selumetinib, for use in patients with plexiform neurofibromas, a common manifestation in the disease neurofibromatosis type one (NF1).

14 Nov 2019

Fight for Sight funds new project to create UK’s first large-scale glaucoma biobank

Fight for Sight is funding a project to create the UK’s first large-scale glaucoma biobank, a new tool that will help personalize glaucoma treatment and identify patients most at risk of sight loss.

14 Nov 2019

Study examines efficacy of nutraceuticals to manage diabetes

Every five minutes, someone in Australia is diagnosed with diabetes. It’s Australia’s fastest growing chronic condition, but as its prevalence grows more people are adding dietary supplements to their diets in the hope of reducing their risk of the disease.

14 Nov 2019

Age-related macular degeneration (AMD) may affect 77 million Europeans by 2050

Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in adults who are more than 50. A new study revealed that the condition might affect 77 million Europeans come 2050.

12 Nov 2019

Blindness News and Research

Samoa shuts down country for mass measles vaccinations

Zebrafish study supports accuracy of CRISPR-Cas9 gene editing tool

Helper protein exacerbates diabetic macular edema

Stem cells do not take the day off on national holidays

Glaucoma risk increased by air pollution

Air pollution associated with greater risk of glaucoma

'African eye worm' hampers efforts to eliminate river blindness, study shows

CTF, DELopen jointly offer unique opportunities to neurofibromatosis research community

Study of 'face blindness' provides clues to what goes wrong in the brain

WHO announces two-year scheme to drive down the price of insulin

Ramping up the body's waste disposal system helps heal diabetics' blood vessels

Nutraceuticals could help prevent diabetes

Study shows importance of targeted antibody treatment for patients with wet macular degeneration

Survey highlights the need to better educate people on risk factors of type 2 diabetes

Improved method for predicting retinopathy of prematurity could reduce unnecessary tests

Understanding how pressure is regulated in the eye could lead to new treatments for glaucoma

FDA grants acceptance to application for selumetinib as treatment for neurofibromatosis

Fight for Sight funds new project to create UK’s first large-scale glaucoma biobank

Study examines efficacy of nutraceuticals to manage diabetes

Age-related macular degeneration (AMD) may affect 77 million Europeans by 2050

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News